哈普洛同一性骨髓的G-CSF原料:对细胞产量,采集效率和宽容性移植组合的影响
Nadira Duraković1,2, Antonija Babić3, Lana Desnica1
1Division of Hematology, Department of Internal Medicine, University Hospital Centre Zagreb, Zagreb, Croatia.
Annals of transplantation
|November 18, 2025
概括
颗粒细胞殖民地刺激因子 (G-CSF) 初始化增强了骨髓采集效率,用于平分母细胞移植. 这种方法可以通过改变移植组合,以达到耐受性特征来降低移植与宿主疾病 (GVHD) 的风险.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 在缺乏匹配捐赠者的患者中,来自单一捐赠者的全源造血干细胞移植 (HSCT) 非常重要.
- 外周血液干细胞往往比骨髓更受青,以实现更快的移植和更好的生存,尽管移植对宿主疾病 (GVHD) 率更高.
- 有限的研究存在于基质细胞殖民地刺激因子 (G-CSF) 的骨髓移植与G-CSF的外周血液干细胞相比.
研究的目的:
- 调查G-CSF初始化对骨髓移植采集效率和组成在平分异性HSCT中的影响.
- 探索G-CSF初始化的潜力,以减轻GVHD风险,同时保持植入疗效.
主要方法:
- 一项雄心勃勃的研究,涉及从61名接受平分相同骨髓HSCT的患者中进行回顾性和前性数据收集.
- 对捐赠者/接受者的人口统计数据,移植细节和结果的医院记录的分析.
- 评估G-CSF原料 (n=17) 和非原料 (n=9) 供体的移植成分和采集时间.
主要成果:
- G-CSF初始化显著提高了骨髓采集效率.
- 化改变了移植组合,显著增加了调节性T细胞和树突细胞含量.
- 这些变化表明转向耐受性免疫特征,可能降低GVHD风险.
- 与观察到的免疫学变化相比,植入疗效保持不变.
结论:
- 骨髓移植的G-CSF初始化可以提高采集效率,并修改移植组合,以潜在地降低GVHD风险在 haploidentical HSCT.
- 该研究的回顾性设计和缺乏对照组限制了最终的因果结论.
- 需要进一步的前性研究来验证这些发现,优化初始化协议,并评估不同类型的供体和调节方案的适用性.
更多相关视频
11:55Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
Published on: March 14, 2011
14.9K
05:32In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
Published on: February 16, 2024
861
相关概念视频
Bone Marrow Sampling and Transplants
845
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
845
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
